Search Resources (English): hpv

Results 41 - 50 of 55

Results

The Pap smear: controversies in practice
Provides an overview of the Pap smear. Covers all aspects of screening for cervical neoplasia, including the rationale behind screening, the role of human Papillomavirus in cervical neoplasia, and more.
Published: 2002
The HPV Vaccine: Information for Parents (and others considering it)  
http://www.whp-apsf.ca/pdf/HPV%20Vaccination%20-%20Information%20for%20Parents%20and%20Others.pdf

Plain language guide explaining the HPV Vaccine

 (See Details)
Published: January 2009
Ten good reasons to be concerned about the human papillomavirus (HPV) vaccination campaign  
http://www.whp-apsf.ca/pdf/Ten%20Good%20Reasons%20.pdf

Outlines the main concerns that the Fédération du Québec pour le planning des naissances (FQPN), along with many women’s, teachers’, nurses’ and youth organizations, have about the vaccination program that was introduced in Quebec against the human papillomavirus (HPV) in hopes of reducing rates of cervical cancer.

Translated and adapted by Women and Health Protection and the Canadian Women’s Health Network.

 (See Details)
Published: October 2008
Human Papilloma Virus (HPV)  
http://www.cfsh.ca/Your_Sexual_Health/STIs-and-HIV/HPV.aspx

Gives basic information about Human Papilloma Virus (HPV), a common sexually transmitted infection (STI). Includes information about testing and treatment.

 (See Details)
Published: 2008
Letter to the editor re: disinformation about HPV vaccine  
http://www.cwhn.ca/resources/pub/globe_letter_jan08.htm

Submitted to the Globe and Mail January 31, 2008 discussing misinformation published in the newspaer about  the HPV vaccine, Gardasil.

 (See Details)
Published: February 6, 2008
HPV, vaccines, and gender: policy considerations June 25, 2007  
http://www.cwhn.ca/sites/default/files/PDF/CWHN_HPVjuly30.pdf

Summarize some of the major questions and concerns to be addressed before there is a full-scale roll-out of an HPV vaccination program.

 (See Details)
Published: June 25, 2007
A population based HPV immunization program in British Columbia: background paper  
http://www.krueger.ca/index.asp?Page=Projects#HPV

Provides information to begin addressing these questions: How many cancers and other diseases might be prevented by such a program? What are the expected side-effects of an HPV vaccine? Should an immunization program be implemented in BC? If so, should it be targeted to specific groups or be implemented population wide? Would an HPV immunization program in BC be cost-effective?

 (See Details)
Published: January 17, 2007
Canadian human papillomavirus vaccine research priorities workshop: Final report - Public Health Agency of Canada  
http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/06pdf/32s1_e.pdf

Report on the proceedings of an invitational HPV Vaccine Research Priorities Workshop on November 17-18, 2005, in Quebec City hosted by The Public Health Agency of Canada (PHAC) and the Canadian Association for Immunization Research and Evaluation (CAIRE), in partnership with the Canadian Institutes of Health Research (CIHR) Institute of Infection and Immunity and the Institute of Cancer Research, held. The workshop was attended by 53 Canadian and international HPV experts and researchers from the areas of vaccines, cancer, and sexually transmitted infections. The purpose of the meeting was to examine the current Canadian and international status of HPV vaccine research and develop national research priorities before the vaccines become approved for use in Canada.

 (See Details)
Published: 2006
Statement on human papillomavirus vaccine  
http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07vol33/acs-02/index-eng.php

Discusses specific elements of the analytic framework for immunization programs in Canada. Makes recommendations about the use of HPV vaccine. Comments on important research gaps for the optimal use of this vaccine in Canada.

 (See Details)
Published: February 2007
Summary basis of decision (SBD) – Gardasil  
http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/phase1-decision/drug-med/sbd_smd_2007_gardasil_102682_e.html

Outlines the scientific and regulatory considerations that factor into Health Canada regulatory decisions related to Gardasil, the vaccine for human papilloma virus.

 (See Details)
Published: March 16, 2007